REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Onemed (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Onemed Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Onemed is an enterprise based in Lithuania. Its main office is in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on October 03, 2003. 7 (2025) employees currently work for UAB Onemed. The company’s latest financial report indicates a net sales revenue increase of 2.37% in 2024. The enterprise’s net profit margin increased by 0.13% in 2024.

Headquarters
Perkunkiemio g. 4A-1
Vilnius; Vilnius county; Postal Code: LT-12128

Contact Details: Purchase the UAB Onemed report to view the information.

Basic Information
Total Employees:
Purchase the UAB Onemed report to view the information.
Registered Capital:
Purchase the UAB Onemed report to view the information.
Financial Auditors:
Purchase the UAB Onemed report to view the information.
Incorporation Date:
October 03, 2003
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Onemed report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
2.37%
Total operating revenue
2.37%
Net Profit (Loss) for the Period
17.11%
Total equity
4.51%
Net Profit Margin
0.13%
Return on Equity (ROE)
0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?